🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This study aims to evaluate the efficacy and safety of pyrotinib in combina...
Status
Active Not Recruiting
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2020-05-30
Trial ID
NCT04398914
Treatments Being Tested
Patients with Stage II-III HER2-positive breast cancer will receive three c...
Status
Recruiting
Location
Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital
Start Date
2026-02-02
Trial ID
NCT07393425
This prospective, response-guided phase II study investigates individualize...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-12-25
Trial ID
NCT07340398
Treatments Being Tested
This study is a prospective, single arm, multi-center clinical trial. The p...
Status
Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2024-12-03
Trial ID
NCT06832904
Treatments Being Tested
This is an open, prospective and interventional clinical study. Patients wi...
Status
Unknown
Location
The First Affiliated Hospital of Xi'an Jiaotong University
Start Date
2021-01-01
Trial ID
NCT05429684
The study is being conducted to evaluate the efficacy, and safety of pyroti...
Status
Unknown
Location
Multiple Locations
Start Date
2021-05
Trial ID
NCT04900311
Treatments Being Tested
This study aims to evaluate the efficacy and safety of pyrotinib in combina...
Status
Terminated
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2019-09-09
Trial ID
NCT04066790
Treatments Being Tested
This study is a phase III clinical trial to explore the efficacy and safety...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11-16
Trial ID
NCT07239271
This study aims to optimize neoadjuvant therapy for HER2-positive breast ca...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT06973525
Treatments Being Tested